SCHEMBL10489299

SCHEMBL10489299

C=CC(=O)OC(CO)COc1ccccc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.52
CYP1A2 P05177 2/20 0.52
AGTR1 P30556 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 2/20 0.47
POLB P06746 2/20 0.44
HTR1A P08908 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
HSD17B10 Q99714 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
RXRA P19793 1/20 0.39
ATM Q13315 1/20 0.38
MAPT P10636 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19766706 0.93 LMNA (0.50) LMNACYP1A2AGTR1SMN1; SMN2KDM4E
SCHEMBL18492245 0.86 KDM4E (0.52) LMNACYP1A2SMN1; SMN2KDM4EALDH1A1
SCHEMBL31512476 0.83 LMNA (0.58) LMNACYP1A2AGTR1SMN1; SMN2KDM4E
SCHEMBL18492223 0.83 HTT (0.46) LMNASMN1; SMN2KDM4EALDH1A1TDP1
SCHEMBL18492218 0.82 CYP1A2 (0.55) LMNACYP1A2AGTR1SMN1; SMN2KDM4E
SCHEMBL18492261 0.80 THRB (0.53) LMNASMN1; SMN2KDM4EPOLBHTR1A
SCHEMBL9447673 0.79 LMNA (0.50) LMNACYP1A2AGTR1SMN1; SMN2KDM4E
Water SCHEMBL21594824 0.79 THRB (0.51) LMNASMN1; SMN2KDM4EPOLBHTR1A
SCHEMBL4194281 0.78 HTT (0.47) LMNASMN1; SMN2KDM4EALDH1A1TDP1
SCHEMBL17213642 0.78 MTNR1A (0.44) LMNACYP1A2AGTR1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9921473-B2 Aromatic glycol ethers as writing monomers in holographic photopolymer formulations COVESTRO DEUTSCHLAND AG (DE) 2018-03-20 US disclosed
US-20170045816-A1 AROMATIC GLYCOL ETHERS AS WRITING MONOMERS IN HOLOGRAPHIC PHOTOPOLYMER FORMULATIONS COVESTRO DEUTSCHLAND AG (DE) 2017-02-16 US disclosed
US-4859562-A Photosensitive mixture and photosensitive recording material produced therefrom with polymeric compound which is reaction product of unsaturated (thio)phosphinic acid iso(thio)cyanate and active hydrogen containing compound HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-22 US disclosed
US-4839254-A Photosensitive mixture and photosensitive recording material produced therefrom with polymeric binder which is reaction product of (thio) phosphinic acidiso (thio) cyanate and active hydrogen containing polymer HOECHST AKTIENGESELLSCHAFT (DE) 1989-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170045816-A1 AROMATIC GLYCOL ETHERS AS WRITING MONOMERS IN HOLOGRAPHIC PHOTOPOLYMER FORMULATIONS MARK3, KDM3A, MAP1LC3B LMNA 1358/4885CYP1A2 44/4885AGTR1 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.